In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Maro OhanianDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Fieke W HoffDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-7128-1255 Vikas KundraDepartment of Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Dimitrios P KontoyiannisDepartment of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-8051-2940 Graciela N Nogueras-GonzalezDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-6350-2206 Javier AdachiDepartment of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-9721-8804 Dawid SchellingerhoutDepartment of Neuroradiology and Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-3659-435X Samuel ShelburneDepartment of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sherry PierceDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Saadia A FaizDepartment of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7284-3945 Yesid AlvaradoDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-1652-7937 Tapan KadiaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Koji SasakiDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-9140-0610 Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8MUniversity of Texas M.D. Anderson Cancer SPORE-LeukemiaP50CA100632 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KONOPLEVA, MARINA Y · 2003 to 2023
$43.7MNCI NIH HHS P30 CA016672NCI NIH HHS P50 CA100632
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
acute leukemiachest CTchest X-raycomputed tomographyinduction chemotherapyleukemiaradiographic
Identifiers
PMID42882849
PMCPMC13664304
What OpenQuestion holds
Textmetadata
Read underepoch 390